Abstract
Rhenium(I) tricarbonyl complexes bearing a 2,4,7,9-tetraphenylphenanthroline ligand, where the 2,9-phenyl groups have either meta- or para-CF3 groups, have been screened against a selection of cell lines. The meta derivative shows anticancer activity against HeLa and A549 cell lines, whereas the para derivative causes proliferation of HL-60 cells, whilst showing toxicity towards A549 cells.
Original language | English |
---|---|
Pages (from-to) | 23963-23966 |
Number of pages | 4 |
Journal | RSC Advances |
Volume | 3 |
Issue number | 46 |
DOIs | |
Publication status | Published - 4 Oct 2013 |